MyFinsight
Home
Blog
About
Contact
Download
Download image
Technology license
$14,086,999
Goodwill
$10,498,539
Investment in oravax
medical
$1,500,000
Cash
$6,904,185
Marketable securities
$3,091,772
Prepaid expenses
$1,150,291
Total non-current
assets
$26,085,538
Total current assets
$11,146,248
Total assets
$37,231,786
Total liabilities and
stockholders equity
$37,231,786
Total liabilities
$15,913,502
Total stockholders
equity
$14,320,390
Total mezzanine
equity
$6,997,894
Accumulated deficit
-$137,562,379
Convertible preferred stock
discount-Series GConvertible...
$6,938,000
Convertible preferred stock
discount-Series HConvertible...
$2,729,083
Series h convertible
preferred stock ...
$1,837,000
Total non-current
liabilities
$9,380,000
Total current
liabilities
$6,533,502
Additional paid in capital
$151,558,433
Convertible preferred
stock, value-Series...
$8,804,000
Common stock, par value
0.001, 1,250,000,000...
$179,812
Preferred stock,
value-Series DConvertible...
$144,524
Convertible preferred
stock, value-Series...
$7,000,000
Convertible preferred
stock, value-Series...
$2,697,977
Contingent consideration
payable, net of current
$9,380,000
Trade and other
payables
$3,180,662
Derivative liability
$2,896,000
License fees payable
$337,130
Dividends payable
$89,728
Due to mymd fl
shareholders
$29,982
Back
Back
Balance Sheet
source: myfinsight.com
Q C TECHNOLOGIES, INC. (QCLS)
Q C TECHNOLOGIES, INC. (QCLS)